A diverse range of viruses have well-established roles as the primary driver of oncogenesis
in various haematological malignancies and solid tumours. Indeed, estimates suggest that …

Background HTLV-1 infection is a neglected disease, despite estimates of 10 million people
infected worldwide and producing life-threatening illnesses in 10% of carriers. Sexual …

Introduction Human T Lymphotropic Virus type 1 (HTLV-1) is a neglected retrovirus
associated with many clinical disorders, most notably Adult T-cell Leukemia/Lymphoma and …

Objectives Human T-lymphotropic virus (HTLV) antenatal screening is not mandatory in
Spain. Surveys conducted decades ago reported HTLV-1 seroprevalence rates of 0.2 …

Human T-cell lymphotropic virus type 1 (HTLV-1) infection is spreading globally at an
uncertain speed. Sexual, mother-to-child, and parenteral exposure are the major …

Background Human T-cell lymphotropic virus type 1 (HTLV-1) is a neglected virus that can
cause severe disease and be transmitted from mother to child through breastfeeding …

Human t-cell lymphotropic virus type 1 (HTLV-1) prevalence in Portugal is low and mainly
affects immigrants from endemic areas where human immunodeficiency virus (HIV) infection …

Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus that is distinguished for its
correlation to myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell …

Abstract Human T‐cell Lymphotropic Virus Type 1 (HTLV‐1) is traditionally linked to severe
conditions such as adult T‐cell leukemia/lymphoma, HTLV‐1‐associated myelopathy, and …

Sweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV)
infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk …